Antipsychotics

Overview

Antipsychotics are a class of medications primarily used to manage psychosis, including symptoms such as hallucinations, delusions, disorganized thinking, agitation, and severe disturbances in perception or behavior. They are most commonly associated with treatment of schizophrenia spectrum disorders, but they are also used in a range of other psychiatric and neurologic contexts, including bipolar disorder, severe depression with psychotic features, delirium-related agitation in selected settings, Tourette syndrome, and behavioral symptoms in some neuropsychiatric conditions. Their role in modern psychiatry is significant because psychosis can markedly affect safety, functioning, relationships, and quality of life.

Antipsychotics are often grouped into first-generation (typical) and second-generation (atypical) agents. In broad terms, first-generation medications are more strongly associated with movement-related adverse effects, while second-generation medications are more often associated with metabolic effects such as weight gain, insulin resistance, and lipid abnormalities, although individual drugs vary considerably. Commonly known examples include haloperidol, chlorpromazine, risperidone, olanzapine, quetiapine, aripiprazole, clozapine, lurasidone, and ziprasidone. These medications differ in receptor activity, side-effect profiles, route of administration, and duration of action.

From a public health perspective, antipsychotics are important not only because of their potential to reduce acute psychotic symptoms and relapse risk, but also because they require careful ongoing monitoring. Research indicates that while these medications can be highly effective for many people, they may also carry meaningful risks, including sedation, orthostatic hypotension, sexual dysfunction, elevated prolactin, tardive dyskinesia, neuroleptic malignant syndrome, QT prolongation, and metabolic syndrome. Some agents are available as long-acting injectable formulations, which may support continuity of treatment in certain circumstances. Clozapine occupies a unique place because studies suggest it can be especially effective in treatment-resistant schizophrenia, though it requires blood monitoring because of risks such as agranulocytosis.

The broader conversation around antipsychotics also includes questions of individual variability, informed consent, quality of life, polypharmacy, and long-term functional outcomes. In clinical practice, conventional care often combines medication with psychotherapy, case management, social support, sleep stabilization, substance-use treatment, and rehabilitation services. In integrative settings, some patients also explore nutrition, stress reduction, mind-body practices, and traditional healing frameworks. Because antipsychotics affect the central nervous system and can interact with other medications and supplements, decisions about their use, adjustment, or discontinuation are generally considered matters for qualified healthcare professionals.